The global Meningococcal Vaccines Market is forecast to surpass US$ 3.66 Bn in 2022. With rising prevalence of meningococcal disease worldwide, the overall sales of meningococcal vaccines are slated to rise at a healthy CAGR of 8.6% between 2022 and 2028, reaching a total of around US$ 6 Bn by 2028.Partnerships betw.
The global Meningococcal Vaccines Market is forecast to surpass US$ 3.66 Bn in 2022. With rising prevalence of meningococcal disease worldwide, the overall sales of meningococcal vaccines are slated to rise at a healthy CAGR of 8.6% between 2022 and 2028, reaching a total of around US$ 6 Bn by 2028.Partnerships betw.
/PRNewswire/ The Meningococcal Vaccines Market Value is expected to record a valuation of USD 4.87 Billion by 2028, Registering to Accelerate at a 9.7%.
[236 Pages Report] Factors Leading to Worldwide Adoption of Meningococcal Vaccination ProgrammesThe global meningococcal vaccines market is expected to be driven by enhanced access to vaccines in low and middle-income countries, growing investments by manufacturers and governments to cope with pandemic meningitis ou.